Skip to content

Clinical trials

Completed Phase 2/3 Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2/3 Status: Completed Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20053
20062
20072
20081
20092
20101
20114
20132
20141
20151
20161
20174
20182
20211
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Ann & Robert H Lurie Children's Hospital of Chicago2
ASLAN Pharmaceuticals1
Ain Shams University1
Alexandria University1
Alpha Biopharma (Jiangsu) Co., Ltd.1
Azienda USL Reggio Emilia - IRCCS1
Bispebjerg Hospital1
British Columbia Cancer Agency1
Cambridge University Hospitals NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms37
Breast Neoplasms4
Fatigue3
Leukemia3
Pain3
Carcinoma, Non-Small-Cell Lung2
Leukemia, Myeloid, Acute2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Prostatic Neoplasms2
Recurrence2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.